{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T14:42:27Z","timestamp":1790260947490,"version":"4.1.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2023,9,15]],"date-time":"2023-09-15T00:00:00Z","timestamp":1694736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,9,15]],"date-time":"2023-09-15T00:00:00Z","timestamp":1694736000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Indian J Pediatr"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1007\/s12098-023-04833-0","type":"journal-article","created":{"date-parts":[[2023,9,15]],"date-time":"2023-09-15T06:01:45Z","timestamp":1694757705000},"page":"1032-1040","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Systemic Lupus Erythematosus in Children"],"prefix":"10.1007","volume":"91","author":[{"given":"Kunal","family":"Chandwar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2187-5186","authenticated-orcid":false,"given":"Amita","family":"Aggarwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,9,15]]},"reference":[{"key":"4833_CR1","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1038\/nrrheum.2010.121","volume":"6","author":"S Kamphuis","year":"2010","unstructured":"Kamphuis S, Silverman ED. Prevalence and burden of pediatric-onset systemic lupus erythematosus. Nat Rev Rheumatol. 2010;6:538\u201346.","journal-title":"Nat Rev Rheumatol."},{"key":"4833_CR2","doi-asserted-by":"publisher","first-page":"2539","DOI":"10.3899\/jrheum.081141","volume":"36","author":"LT Hiraki","year":"2009","unstructured":"Hiraki LT, Benseler SM, Tyrrell PN, Harvey E, Hebert D, Silverman ED. Ethnic differences in pediatric systemic lupus erythematosus. J Rheumatol. 2009;36:2539\u201346.","journal-title":"J Rheumatol."},{"key":"4833_CR3","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-020-04766-3","volume":"41","author":"V Shobha","year":"2021","unstructured":"Shobha V, Aggarwal A, Rajasekhar L, et al. Indian SLE Inception cohort for Research (INSPIRE): the design of a multi-institutional cohort. Rheumatol Int. 2021;41:887894.","journal-title":"Rheumatol Int."},{"key":"4833_CR4","unstructured":"Aggarwal A, Rajasekhar L, Ghosh P, et al. Juvenile onset SLE in India-data from a multi-institutional inception (INSPIRE) Cohort of Systemic Lupus Erythematosus [abstract]. Arthritis Rheumatol. 2022;74 (suppl 9). Available at: https:\/\/acrabstracts.org\/abstract\/juvenile-onset-sle-in-india-data-from-a-multi-institutional-inception-inspire-cohort-of-systemic-lupus-erythematosus\/. Accessed on 14 Mar 2023."},{"key":"4833_CR5","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1177\/0961203314563817","volume":"24","author":"T Tarr","year":"2015","unstructured":"Tarr T, D\u00e9rfalvi B, Gy\u0151ri N, et al. Similarities and differences between pediatric and adult patients with systemic lupus erythematosus. Lupus. 2015;24:796\u2013803.","journal-title":"Lupus."},{"key":"4833_CR6","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1136\/annrheumdis-2018-214819","volume":"78","author":"M Aringer","year":"2019","unstructured":"Aringer M, Costenbader K, Daikh D, et al. European league against rheumatism\/American College of Rheumatology classification criteria for systemic lupus erythematosus. Ann Rheum Dis. 2019;78:1151\u20139.","journal-title":"Ann Rheum Dis."},{"key":"4833_CR7","doi-asserted-by":"publisher","first-page":"2677","DOI":"10.1002\/art.34473","volume":"64","author":"M Petri","year":"2012","unstructured":"Petri M, Orbai AM, Alarc\u00f3n GS, et al. Derivation and validation of the systemic lupus international collaborating clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum. 2012;64:2677\u201386.","journal-title":"Arthritis Rheum."},{"key":"4833_CR8","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1002\/art.1780400928","volume":"40","author":"MC Hochberg","year":"1997","unstructured":"Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997;40:1725.","journal-title":"Arthritis Rheum."},{"key":"4833_CR9","doi-asserted-by":"publisher","first-page":"1093213","DOI":"10.3389\/fmed.2022.1093213","volume":"9","author":"B Lerkvaleekul","year":"2022","unstructured":"Lerkvaleekul B, Chobchai P, Rattanasiri S, Vilaiyuk S. Evaluating performance of the 2019 EULAR\/ACR, 2012 SLICC, and 1997 ACR criteria for classifying adult-onset and childhood-onset systemic lupus erythematosus: a systematic review and meta-analysis. Front Med (Lausanne). 2022;9:1093213.\u00a0","journal-title":"Front Med (Lausanne)."},{"key":"4833_CR10","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1159\/000518321","volume":"183","author":"X Huang","year":"2022","unstructured":"Huang X, Jia N, Xiao F, et al. Differences in the clinical manifestations and mortality of systemic lupus erythematosus onset in children and adults: a systematic review and meta-analysis. Int Arch Allergy Immunol. 2022;183:116\u201326.","journal-title":"Int Arch Allergy Immunol."},{"key":"4833_CR11","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1111\/1756-185X.12419","volume":"18","author":"A Aggarwal","year":"2015","unstructured":"Aggarwal A, Srivastava P. Childhood onset systemic lupus erythematosus: how is it different from adult SLE? Int J Rheum Dis. 2015;18:182\u201391.","journal-title":"Int J Rheum Dis."},{"key":"4833_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1546-0096-13-1","volume":"13","author":"D Chiewchengchol","year":"2015","unstructured":"Chiewchengchol D, Murphy R, Edwards SW, Beresford MW. Mucocutaneous manifestations in juvenile-onset systemic lupus erythematosus: a review of literature. Pediatr Rheumatol Online J. 2015;13:1.\u00a0","journal-title":"Pediatr Rheumatol Online J."},{"key":"4833_CR13","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1097\/MOP.0000000000001101","volume":"34","author":"T Dowsett","year":"2022","unstructured":"Dowsett T, Oni L. Renal manifestations of paediatric systemic lupus erythematosus. Curr Opin Pediatr. 2022;34:203\u20138.","journal-title":"Curr Opin Pediatr."},{"key":"4833_CR14","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/S2352-4642(22)00157-2","volume":"6","author":"S Appenzeller","year":"2022","unstructured":"Appenzeller S, Pereira DR, Julio PR, Reis F, Rittner L, Marini R. Neuropsychiatric manifestations in childhood-onset systemic lupus erythematosus. Lancet Child Adolesc Health. 2022;6:571\u201381.","journal-title":"Lancet Child Adolesc Health."},{"key":"4833_CR15","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1177\/09612033221093508","volume":"31","author":"H Kisaoglu","year":"2022","unstructured":"Kisaoglu H, Baba O, Kalyoncu M. Hematologic manifestations of juvenile systemic lupus erythematosus: An emphasis on anemia. Lupus. 2022;31:730\u20136.","journal-title":"Lupus."},{"key":"4833_CR16","doi-asserted-by":"publisher","first-page":"1492","DOI":"10.1093\/rheumatology\/kem182","volume":"46","author":"HH Yu","year":"2007","unstructured":"Yu HH, Wang LC, Lee JH, Lee CC, Yang YH, Chiang BL. Lymphopenia is associated with neuropsychiatric manifestations and disease activity in paediatric systemic lupus erythematosus patients. Rheumatology (Oxford). 2007;46:1492\u20134.","journal-title":"Rheumatology (Oxford)."},{"key":"4833_CR17","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1002\/pbc.20970","volume":"47","author":"R Hazzan","year":"2006","unstructured":"Hazzan R, Mukamel M, Yacobovich J, Yaniv I, Tamary H. Risk factors for future development of systemic lupus erythematosus in children with idiopathic thrombocytopenic purpura. Pediatr Blood Cancer. 2006;47:657\u20139.","journal-title":"Pediatr Blood Cancer."},{"key":"4833_CR18","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/1546-0096-8-27","volume":"8","author":"PN Malleson","year":"2010","unstructured":"Malleson PN, Mackinnon MJ, Sailer-Hoeck M, Spencer CH. Review for the generalist: The antinuclear antibody test in children - when to use it and what to do with a positive titer. Pediatr Rheumatol Online J. 2010;8:27.\u00a0","journal-title":"Pediatr Rheumatol Online J."},{"key":"4833_CR19","doi-asserted-by":"crossref","unstructured":"Aggarwal A, Gupta R, Chatterjee R, et al; on behalf of INSPIRE. POS0773\u2005autoantibodies in a multi-institutional indian cohort (INSPIRE) of SLE patients: prevalence, cluster analysis and phenotype association Ann Rheum Dis. 2022;81:673.","DOI":"10.1136\/annrheumdis-2022-eular.4173"},{"key":"4833_CR20","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1136\/annrheumdis-2019-215089","volume":"78","author":"A Fanouriakis","year":"2019","unstructured":"Fanouriakis A, Kostopoulou M, Alunno A, et al. 2019 update of the EULAR recommendations for the management of systemic lupus erythematosus. Ann Rheum Dis. 2019;78:736\u201345.","journal-title":"Ann Rheum Dis."},{"key":"4833_CR21","doi-asserted-by":"publisher","first-page":"1788","DOI":"10.1136\/annrheumdis-2016-210960","volume":"76","author":"N Groot","year":"2017","unstructured":"Groot N, de Graeff N, Avcin T, et al. European evidence-based recommendations for diagnosis and treatment of childhood-onset systemic lupus erythematosus: the SHARE initiative. Ann Rheum Dis. 2017;76:1788\u201396.","journal-title":"Ann Rheum Dis."},{"key":"4833_CR22","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1002\/acr.25045","volume":"75","author":"AR Bass","year":"2023","unstructured":"Bass AR, Chakravarty E, Akl EA, et al. 2022 American College of Rheumatology guideline for vaccinations in patients with rheumatic and musculoskeletal diseases. Arthritis Care Res (Hoboken). 2023;75:449\u201364.","journal-title":"Arthritis Care Res (Hoboken)."},{"key":"4833_CR23","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1002\/art.41480","volume":"72","author":"R Borucki","year":"2020","unstructured":"Borucki R, Werth VP. Expert perspective: an evidence-based approach to refractory cutaneous lupus erythematosus. Arthritis Rheumatol. 2020;72:1777\u201385.","journal-title":"Arthritis Rheumatol."},{"key":"4833_CR24","doi-asserted-by":"crossref","unstructured":"Chalhoub NE, Wenderfer SE, Levy DM, et al. Childhood arthritis and rheumatology research alliance lupus nephritis work group and the pediatric rheumatology European society lupus working party. international consensus for the dosing of corticosteroids in childhood-onset systemic lupus erythematosus with proliferative lupus nephritis. Arthritis Rheumatol. 2022;74:263-73.","DOI":"10.1002\/art.41930"},{"key":"4833_CR25","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1177\/09612033211034567","volume":"30","author":"S Sawhney","year":"2021","unstructured":"Sawhney S, Agarwal M. Rituximab use in pediatric systemic lupus erythematosus: Indications, efficacy and safety in an Indian cohort. Lupus. 2021;30:1829\u201336.","journal-title":"Lupus."},{"key":"4833_CR26","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1002\/art.42092","volume":"74","author":"S Arora","year":"2022","unstructured":"Arora S, Rovin BH. Expert perspective: an approach to refractory lupus nephritis. Arthritis Rheumatol. 2022;74:915\u201326.","journal-title":"Arthritis Rheumatol."},{"key":"4833_CR27","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1177\/09612033211028653","volume":"30","author":"RA Levy","year":"2021","unstructured":"Levy RA, Gonzalez-Rivera T, Khamashta M, et al. 10 years of belimumab experience: What have we learnt? Lupus. 2021;30:1705\u201321.","journal-title":"Lupus."},{"key":"4833_CR28","doi-asserted-by":"publisher","first-page":"275","DOI":"10.2217\/imt-2020-0017","volume":"12","author":"E Anderson","year":"2020","unstructured":"Anderson E, Furie R. Anifrolumab in systemic lupus erythematosus: current knowledge and future considerations. Immunotherapy. 2020;12:275\u201386.","journal-title":"Immunotherapy."},{"key":"4833_CR29","doi-asserted-by":"publisher","first-page":"2070","DOI":"10.1016\/S0140-6736(21)00578-X","volume":"397","author":"BH Rovin","year":"2021","unstructured":"Rovin BH, Teng YKO, Ginzler EM, et al. Efficacy and safety of voclosporin versus placebo for lupus nephritis (AURORA 1): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial. Lancet. 2021;397:2070\u201380.","journal-title":"Lancet."},{"key":"4833_CR30","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1016\/S0140-6736(22)02546-6","volume":"401","author":"M Petri","year":"2023","unstructured":"Petri M, Bruce IN, D\u00f6rner T, et al. Baricitinib for systemic lupus erythematosus: a double-blind, randomised, placebo-controlled, phase 3 trial (SLE-BRAVE-II). Lancet. 2023;401:1011\u20139.","journal-title":"Lancet."},{"key":"4833_CR31","doi-asserted-by":"crossref","unstructured":"Liossis SN, Staveri C. What's new in the treatment of systemic lupus erythematosus. Front Med (Lausanne). 2021;8:655100.","DOI":"10.3389\/fmed.2021.655100"},{"key":"4833_CR32","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1542\/peds.26.4.570","volume":"26","author":"CD Cook","year":"1960","unstructured":"Cook CD, Wedgwood RJ, Craig JM, Hartmann JR, Janeway CA. Systemic lupus erythematosus. Pediatrics. 1960;26:570\u201385.","journal-title":"Pediatrics"},{"key":"4833_CR33","doi-asserted-by":"publisher","first-page":"1867","DOI":"10.1177\/0961203318791046","volume":"27","author":"A Aggarwal","year":"2018","unstructured":"Aggarwal A, Phatak S, Srivastava P, Lawrence A, Agarwal V, Misra R. Outcomes in juvenile onset lupus: single center cohort from a developing country. Lupus. 2018;27:1867\u201375.","journal-title":"Lupus."},{"issue":"5","key":"4833_CR34","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1177\/0961203315619031","volume":"25","author":"P Srivastava","year":"2016","unstructured":"Srivastava P, Abujam B, Misra R, Lawrence A, Agarwal V, Aggarwal A. Outcome of lupus nephritis in childhood onset SLE in North and Central India: single-centre experience over 25 years. Lupus. 2016;25:547\u201357.\u00a0","journal-title":"Lupus."},{"key":"4833_CR35","doi-asserted-by":"crossref","unstructured":"Smith E, Aggarwal A, Avicin T, et al. Towards development of treat to target (T2T) in childhood-onset systemic lupus erythematosus: PReS-endorsed overarching principles and points-to-consider from an International Task Force. Ann Rheum Dis. 2023;82:788-98.","DOI":"10.1136\/ard-2022-223328"},{"key":"4833_CR36","doi-asserted-by":"publisher","first-page":"2124","DOI":"10.1038\/s41591-022-02017-5","volume":"28","author":"A Mackensen","year":"2022","unstructured":"Mackensen A, M\u00fcller F, Mougiakakos D, et al. Anti-CD19 CAR T cell therapy for refractory systemic lupus erythematosus. Nat Med. 2022;28:2124\u201332.","journal-title":"Nat Med."}],"container-title":["Indian Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12098-023-04833-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12098-023-04833-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12098-023-04833-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,20]],"date-time":"2024-09-20T09:37:06Z","timestamp":1726825026000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12098-023-04833-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,15]]},"references-count":36,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["4833"],"URL":"https:\/\/doi.org\/10.1007\/s12098-023-04833-0","relation":{},"ISSN":["0019-5456","0973-7693"],"issn-type":[{"value":"0019-5456","type":"print"},{"value":"0973-7693","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,15]]},"assertion":[{"value":"23 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 August 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 September 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}